The University of Wisconsin-Madison is resuming their COVID-19 vaccine trial next week.
Thirty-six people got the first of two shots before the trial was put on hold in September after a participant had a serious health issue. They’re testing the vaccine developed by British pharmaceutical company AstraZeneca in partnership with Oxford University. The university will begin enrolling more patients in the trial starting this coming week.
